IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis

被引:323
作者
Lubberts, E
Joosten, LAB
Oppers, B
van den Bersselaar, L
Coenen-de Roo, CJJ
Kolls, JK
Schwarzenberger, P
van de Loo, FAJ
van den Berg, WB
机构
[1] Univ Nijmegen, Med Ctr St Radboud, Rheumatol Res Lab, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands
[2] NV Organon, Dept Pharmacol, NL-5340 BH Oss, Netherlands
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA
关键词
D O I
10.4049/jimmunol.167.2.1004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell IL-17 displays proinflammatory properties and is expressed in the synovium of patients with rheumatoid arthritis. Its contribution to the arthritic process has not been identified. Here, we show that blocking of endogenous IL-17 in the autoimmune collagen-induced arthritis model results in suppression of arthritis. Also, joint damage was significantly reduced. In contrast, overexpression of IL-17 enhanced collagen arthritis. Moreover, adenoviral IL-17 injected in the knee joint of type II collagen-immunized mice accelerated the onset and aggravated the synovial inflammation at the site. Radiographic and histologic analysis showed markedly increased joint destruction. Elevated levels of IL-1 beta protein were found in synovial tissue. Intriguingly, blocking of IL-1 alpha beta with neutralizing Abs had no effect on the IL-17-induced inflammation and joint damage in the knee joint, implying an IL-1 independent pathway. This direct potency of IL-17 was underscored in the unabated IL-17-induced exaggeration of bacterial cell wall-induced arthritis in IL-1 beta (-/-) mice. In conclusion, this data shows that IL-17 contributes to joint destruction and identifies an IL-1-independent role of IL-17. These findings suggest IL-17 to be a novel target for the treatment of destructive arthritis and may have implications for tissue destruction in other autoimmune diseases.
引用
收藏
页码:1004 / 1013
页数:10
相关论文
共 48 条
[31]   Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis [J].
Mauri, C ;
Williams, RO ;
Walmsley, M ;
Feldmann, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1511-1518
[32]   Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis [J].
McInnes, IB ;
Leung, BP ;
Sturrock, RD ;
Field, M ;
Liew, FY .
NATURE MEDICINE, 1997, 3 (02) :189-195
[33]   The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis [J].
McInnes, IB ;
AlMughales, J ;
Field, M ;
Leung, BP ;
Huang, FP ;
Dixon, R ;
Sturrock, RD ;
Wilkinson, PC ;
Liew, FY .
NATURE MEDICINE, 1996, 2 (02) :175-182
[34]   Th1/Th2 cytokine balance in arthritis [J].
Miossec, P ;
van den Berg, W .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2105-2115
[35]  
Ruchatz H, 1998, J IMMUNOL, V160, P5654
[36]  
SCHALKWIJK J, 1987, BRIT J EXP PATHOL, V68, P81
[37]   Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction [J].
Schwandner, R ;
Yamaguchi, K ;
Cao, ZD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1233-1239
[38]  
Schwarzenberger P, 1998, J IMMUNOL, V161, P6383
[39]   Interleukin-17:: A new bone acting cytokine in vitro [J].
Van Bezooijen, RL ;
Farih-Sips, HCM ;
Papapoulos, SE ;
Löwik, CWGM .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1513-1521
[40]  
VANDELOO FAJ, 1995, ARTHRITIS RHEUM, V38, P164